Perrigo (PRGO) FCF Payout Ratio Growth (3y) (2016 - 2026)
Perrigo (PRGO) FCF Payout Ratio Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.93 Bn | 32.19 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | 34.17% |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | -43.00% |
| 5 | United Therapeutics | 23.05 Bn | 20.89 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.24 Bn | 18.43 Bn | 1.16 Bn | 37.03% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn | - |
| 10 | Perrigo | 1.43 Bn | 1.07 Bn | 325.50 Mn | 67.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 67.96% |
| Dec 31, 2025 | -8.86% |
| Sep 27, 2025 | 51.74% |
| Jun 28, 2025 | 42.24% |
| Mar 29, 2025 | -40.54% |
| Dec 31, 2024 | 41.72% |
| Sep 28, 2024 | 196.30% |
| Jun 29, 2024 | -86.27% |
| Mar 30, 2024 | -25.30% |
| Dec 31, 2023 | 29.53% |
| Sep 30, 2023 | -5.88% |
| Jul 1, 2023 | 119.60% |
| Apr 1, 2023 | -254.49% |
| Dec 31, 2022 | -27.69% |
| Oct 1, 2022 | 11.58% |
| Jul 2, 2022 | -41.22% |
| Apr 2, 2022 | 18.13% |
| Dec 31, 2021 | -48.03% |
| Oct 2, 2021 | -18.87% |
| Jul 3, 2021 | -39.90% |